Laura Prendergast
Stock Analyst at Stifel
(4.77)
# 118
Out of 5,152 analysts
17
Total ratings
56.25%
Success rate
73.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $22.56 | +112.77% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $9.97 | +130.69% | 1 | Feb 11, 2026 | |
| RVMD Revolution Medicines | Maintains: Buy | $85 → $170 | $99.64 | +70.61% | 4 | Jan 22, 2026 | |
| TNGX Tango Therapeutics | Initiates: Buy | $15 | $16.83 | -10.87% | 1 | Dec 4, 2025 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.63 | +113.33% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $100.13 | +34.82% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.05 | +290.24% | 2 | Oct 16, 2025 | |
| ERAS Erasca | Initiates: Buy | $4 | $15.54 | -74.26% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $37.46 | -57.29% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.46 | +550.41% | 2 | Aug 14, 2024 |
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $22.56
Upside: +112.77%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $9.97
Upside: +130.69%
Revolution Medicines
Jan 22, 2026
Maintains: Buy
Price Target: $85 → $170
Current: $99.64
Upside: +70.61%
Tango Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $15
Current: $16.83
Upside: -10.87%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $5.63
Upside: +113.33%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $100.13
Upside: +34.82%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.05
Upside: +290.24%
Erasca
Oct 16, 2025
Initiates: Buy
Price Target: $4
Current: $15.54
Upside: -74.26%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $37.46
Upside: -57.29%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.46
Upside: +550.41%